Consultas particulares e convênio: Hospital Moinhos de Vento, rua Tiradentes, 333,
12º andar, sala 6 | Porto Alegre - RS

Consultas particulares: Clínica Brenol, rua Vinte e quatro de outubro, 1312, sala 202,
Bairro Auxiliadora | Porto Alegre - RS

Dr. Claiton Brenol atua ainda como pesquisador vinculado ao Programa de Pós-Graduação da UFRGS e possui dezenas de artigos e capítulos publicados.

High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study.

de Resende Guimarães MFB, Rodrigues CEM, Gomes KWP, Machado CJ, Brenol CV, Krampe SF, de Andrade NPB, Kakehasi AM.

Adv Rheumatol. 2019 Oct 16;59(1):44. doi: 10.1186/s42358-019-0089-1.

High Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study.

Gomides APM, Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RD, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRC, Resende GG, Bonfiglioli KR, Carriço H, Sauma MFLC, Sauma ML, Medeiros JB, Pereira IA, Castro GRW, Brenol CV, Xavier RM, Mota LMH, Pinheiro GRC.

J Pharm Pract. 2019 Aug 26:897190019869158. doi: 10.1177/0897190019869158. [Epub ahead of print]

PMID:

Latent tuberculosis infection in patients with rheumatic diseases.

Anton C, Machado FD, Ramirez JMA, Bernardi RM, Palominos PE, Brenol CV, Mello FCQ, Silva DR.

J Bras Pneumol. 2019 Apr 25;45(2):e20190023. doi: 10.1590/1806-3713/e20190023. Review. English, Portuguese.

PMID:

Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.

Pileggi GS, Da Mota LMH, Kakehasi AM, De Souza AW, Rocha A, de Melo AKG, da Fonte CAM, Bortoletto C, Brenol CV, Marques CDL, Zaltman C, Borba EF, Reis ER, Freire EAM, Klumb EM, Christopoulos GB, Laurindo IMM, Ballalai I, Da Costa IP, Michelin L, de Azevêdo Valadares LD, Chebli LA, Lacerda M, Toscano MAF, Yazbek MA, De Abreu Vieira RMR, Magalhães R, Kfouri R, Richtmann R, Merenlender SDCS, Valim V, De Assis MR, Kowalski SC, Trevisani VFM.

Adv Rheumatol. 2019 Apr 29;59(1):17. doi: 10.1186/s42358-019-0056-x.

PMID:

Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.

Ranza R, de la Vega MC, Laurindo IMM, Gómez MG, Titton DC, Kakehasi AM, Brigante A, Benitez A, Ranzolin A, Granel A, Cappuccio AM, Quinteros A, Hayata ALS, Smichowski A, Duarte ÂLBP, Kahlow BS, Andia CS, Brenol CV, Velozo E, Mussano E, Soriano ER, Christopoulos GB, da Rocha Castelar Pinheiro G, de Castro GRW, Casado G, da Silveira Carvalho HM, Exeni IE, da Silveira IG, Petkovic I, Pereira IA, da Costa IP, Rosa JE, Miranda JRS, de Moraes JCB, Bertolo MB, Buhl M, Lázaro MA, da Sauma MFLC, de Medeiros Pinheiro M, Díaz M, de Vechi MVSS, Cerda OL, Astesana P, Curi PF, Louzada-Jr P, Teodoro RB, Toledo RA, Papasidero S, Valim V, Fernandes V, Saurit V, Bianchi WA; BIOBADABRASIL study group, Sociedade Brasileira de Reumatologia and of the BIOBADASAR study group, Sociedad Argentina de Reumatologia, de Melo Costa Pinto R, Descalzo MA, Gomez-Reino JJ.

Clin Rheumatol. 2019 Aug;38(8):2129-2139. doi: 10.1007/s10067-019-04516-2. Epub 2019 Apr 17.

Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Gomides APM, de Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRDC, Resende GG, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, de Medeiros JB, Pereira IA, de Castro GRW, Brenol CV, Xavier RM, da Mota LMH, Pinheiro GDRC.

PLoS One. 2019 Apr 4;14(4):e0215198. doi: 10.1371/journal.pone.0215198. eCollection 2019.

Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.

Gomides APM, de Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRDC, Resende GG, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, de Medeiros JB, Pereira IA, de Castro GRW, Brenol CV, Xavier RM, da Mota LMH, Pinheiro GDRC.

PLoS One. 2019 Mar 1;14(3):e0213219. doi: 10.1371/journal.pone.0213219. eCollection 2019. Erratum in: PLoS One. 2019 Apr 4;14(4):e0215198.

The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.

da Rocha Castelar-Pinheiro G, Vargas-Santos AB, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Resende Guimarães MFB, Bonfiglioli KR, Sauma MFLDC, Pereira IA, Brenol CV, Coutinho ESF, da Mota LMH.

Adv Rheumatol. 2018 Jun 28;58(1):9. doi: 10.1186/s42358-018-0017-9.

2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis.

Mota LMHD, Kakehasi AM, Gomides APM, Duarte ALBP, Cruz BA, Brenol CV, de Albuquerque CP, Castelar Pinheiro GDR, Laurindo IMM, Pereira IA, Bertolo MB, Ubirajara Silva de Souza MPG, de Freitas MVC, Louzada-Júnior P, Xavier RM, Giorgi RDN.

Adv Rheumatol. 2018 May 24;58(1):2. doi: 10.1186/s42358-018-0005-0.

Treating psoriatic arthritis to target: discordance between physicians and patients' assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort.

Ferreira MF, Kohem CL, Xavier RM, Abegg E, Martins OS, Resmini MB, de Mello AL, de Almeida Menegat F, Hax V, Gasparin AA, Brenol CV, de Andrade NPB, Viecceli D, Brenol JCT, Palominos PE.

Clin Rheumatol. 2019 Mar;38(3):961-968. doi: 10.1007/s10067-018-4383-9. Epub 2018 Dec 3.

Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.

Cecconi M, Ranza R, Titton DC, Moraes JCB, Bertolo M, Bianchi W, Brenol C, Carvalho HM, de Castro GRW, Costa IP, Cunha MFL, Duarte Â, Fernandes V, Freire M, Louzada-Junior P, Macieira JC, Miranda JRS, Pereira IA, Pinheiro GRC, Stadler B, Toledo RA, Valim V, Descalzo MA, Pinto RMC, Laurindo I.

J Clin Rheumatol. 2018 Oct 25. doi: 10.1097/RHU.0000000000000935. [Epub ahead of print]

Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses.

Lomonte ABV, Radominski SC, Marcolino FMD, Brenol CV, Zerbini CAF, García EG, Akylbekova EL, Rojo R, de Leon DP.

Medicine (Baltimore). 2018 Aug;97(31):e11609. doi: 10.1097/MD.0000000000011609.

Vaccination Recommendations for Adults With Autoimmune Inflammatory Rheumatic Diseases in Latin America.

Brenol CV, Azevedo VF, Bonvehi PE, Coral-Alvarado PX, Granados J, Muñoz-Louis R, Pineda C, Vizzotti C.

J Clin Rheumatol. 2018 Apr;24(3):138-147. doi: 10.1097/RHU.0000000000000624.

Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis.

do Espírito Santo RC, Pompermayer MG, Bini RR, Olszewski V, Teixeira EG, Chakr R, Xavier RM, Brenol CV.

Rheumatol Int. 2018 Mar;38(3):415-423. doi: 10.1007/s00296-017-3894-z. Epub 2017 Nov 27.

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.

Chakr RMDS, Brenol C, Ranzolin A, Bernardes A, Dalosto AP, Ferrari G, Scalco S, Olszewski V, Kohem C, Monticielo O, Brenol JCT, Xavier RM.

Rev Bras Reumatol Engl Ed. 2017 Sep - Oct;57(5):403-411. doi: 10.1016/j.rbre.2017.01.004. Epub 2017 Feb 10. English, Portuguese.

Correlation between cellular expression of complement regulatory proteins with depletion and repopulation of B-lymphocytes in peripheral blood of patients with rheumatoid arthritis treated with rituximab.

Viecceli D, Garcia MP, Schneider L, Alegretti AP, Silva CK, Ribeiro AL, Brenol CV, Xavier RM.

Rev Bras Reumatol Engl Ed. 2017 Sep - Oct;57(5):385-391. doi: 10.1016/j.rbre.2016.09.007. Epub 2016 Oct 18. English, Portuguese.

Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas - BiobadaBrasil).

Yonekura CL, Oliveira RDR, Titton DC, Ranza R, Ranzolin A, Hayata AL, Duarte Â, Silveira IG, Carvalho HMDS, Moraes JCB, Abreu MM, Valim V, Bianchi W, Brenol CV, Pereira IA, Costa I, Macieira JC, Miranda JRS, Guedes-Barbosa LS, Bertolo MB, Sauma MFLDC, Silva MBG, Freire M, Scheinberg MA, Toledo RA, Oliveira SKF, Fernandes V, Pinheiro MM, Castro G, Vieira WP, Baaklini CE, Ruffino-Netto A, Pinheiro GDRC, Laurindo IMM, Louzada-Junior P.

Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:477-483. doi: 10.1016/j.rbre.2017.05.005. Epub 2017 Jul 22. English, Portuguese.

Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents.

Garziera G, Morsch ALB, Otesbelgue F, Staub FL, Palominos PE, Brenol CV, Silva DR.

Clin Rheumatol. 2017 Aug;36(8):1891-1896. doi: 10.1007/s10067-017-3714-6. Epub 2017 Jun 6.

Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.

de Andrade NPB, da Silva Chakr RM, Xavier RM, Viecceli D, Correa RHB, de Oliveira Filho CM, Brenol CV.

Rheumatol Int. 2017 Jun;37(6):993-997. doi: 10.1007/s00296-017-3695-4. Epub 2017 Mar 14.

CCR5Δ32 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study.

Toson B, Dos Santos EJ, Adelino JE, Sandrin-Garcia P, Crovella S, Louzada-Júnior P, Oliveira RD, Pedroza LS, de Fátima Lobato Cunha Sauma M, de Lima CP, Barbosa FB, Brenol CV, Xavier RM, Chies JA, Veit TD.

Rheumatology (Oxford). 2017 Mar 1;56(3):495-497. doi: 10.1093/rheumatology/kew398. No abstract available.

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.

Chakr RM, Brenol C, Ranzolin A, Bernardes A, Dalosto AP, Ferrari G, Scalco S, Olszewski V, Kohem C, Monticielo O, Brenol JC, Xavier RM.

Rev Bras Reumatol. 2016 Dec 18. pii: S0482-5004(16)30173-5. doi: 10.1016/j.rbr.2016.11.004. [Epub ahead of print] English, Portuguese.

Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

Glesse N, Vianna P, Paim LMG, Matte MCC, Aguiar AKK, Palhano PL, Monticielo OA, Brenol CV, Xavier RM, Chies JAB.

Lupus. 2017 Jun;26(7):746-755. doi: 10.1177/0961203316678671. Epub 2016 Dec 5.

Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis Brazilian patients.

Cavalcanti CA, Silva Jde A, Pita Wde B, Veit TD, Monticielo OA, Xavier RM, Brenol JC, Brenol CV, Fragoso TS, Barbosa AD, Duarte ÂL, Oliveira RD, Louzada-Júnior P, Donadi EA, Crovella S, Chies JA, Sandrin-Garcia P.

Mol Biol Rep. 2016 Jan;43(1):41-51. doi: 10.1007/s11033-015-3937-z. Epub 2015 Dec 19.

Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database.

Gvozdenović E, Wolterbeek R, Allaart CF, Brenol C, Dougados M, Emery P, Ferraccioli G, van der Heijde D, Huizinga TW, Kay J, Martin Mola E, Moots RJ, da Silva JA, Smolen J, Veale D, Landewé RB.

J Clin Rheumatol. 2015 Oct;21(7):349-54. doi: 10.1097/RHU.0000000000000296.

Erratum to: Proper management of rheumatoid arthritis in Latin America. What the guidelines say?

Brenol CV, Nava JI, Soriano ER.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S57. doi: 10.1007/s10067-015-3058-z. No abstract available.

Rheumatoid arthritis in Latin America: the importance of an early diagnosis.

da Mota LM, Brenol CV, Palominos P, Pinheiro Gda R.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S29-44. doi: 10.1007/s10067-015-3015-x. Epub 2015 Jul 25. Review.

Proper management of rheumatoid arthritis in Latin America. What the guidelines say?

Brenol CV, Nava JI, Soriano ER.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S51-5. doi: 10.1007/s10067-015-3016-9. Epub 2015 Jul 23. Review. Erratum in: Clin Rheumatol. 2015 Mar;34 Suppl 1:S57.

[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].

Mota LM, Cruz BA, Brenol CV, Pollak DF, Pinheiro Gda R, Laurindo IM, Pereira IA, Carvalho JF, Bertolo MB, Pinheiro Mde M, Freitas MV, Silva NA, Louzada-Júnior P, Sampaio-Barros PD, Giorgi RD, Lima RA, Andrade LE.

Rev Bras Reumatol. 2015 May-Jun;55(3):281-309. doi: 10.1016/j.rbr.2014.06.006. Epub 2014 Oct 13. Review. Portuguese.

The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.

Veit TD, Chies JA, Switala M, Wagner B, Horn PA, Busatto M, Brenol CV, Tavares Brenol JC, Machado Xavier R, Rebmann V.

PLoS One. 2015 Apr 8;10(4):e0123838. doi: 10.1371/journal.pone.0123838. eCollection 2015.

Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.

Fafá BP, Louzada-Junior P, Titton DC, Zandonade E, Ranza R, Laurindo I, Peçanha P, Ranzolin A, Hayata AL, Duarte A, Silveira IG, Costa I, Macieira JC, Guedes-Barbosa LS, Bertolo MB, Sauma MF, Silva MB, Freire M, Scheinberg MA, Fernandes V, Bianchi W, Miranda JR, Pinheiro GR, Carvalho HM, Brenol CV, Pereira IA, de Castro GR, de Morais JC, Oliveira SK, de Abreu MM, Toledo RA, Pinheiro MM, Vieira WP, Valim V; BIOBADABRASIL.

Clin Rheumatol. 2015 May;34(5):921-7. doi: 10.1007/s10067-015-2929-7. Epub 2015 Apr 8.

Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.

Brenol CV, da Chakr RM, Andrade NP, Toni M, Laurindo IM, Brenol JC, Xavier RM.

Clin Rheumatol. 2015 Oct;34(10):1781-5. doi: 10.1007/s10067-015-2915-0. Epub 2015 Mar 15.

Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.

da Silva Chakr RM, Brenol JC, Behar M, Mendonça JA, Kohem CL, Monticielo OA, Brenol CV, Xavier RM.

PLoS One. 2015 Mar 4;10(3):e0118620. doi: 10.1371/journal.pone.0118620. eCollection 2015.

[Anti-Müllerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review].

Gasparin AA, Chakr RM, Brenol CV, Palominos PE, Xavier RM, Souza L, Brenol JC, Monticielo OA.

Rev Bras Reumatol. 2015 Jul-Aug;55(4):363-7. doi: 10.1016/j.rbr.2014.05.008. Epub 2014 Nov 26. Review. Portuguese.

HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil.

Veit TD, de Lima CP, Cavalheiro LC, Callegari-Jacques SM, Brenol CV, Brenol JC, Xavier RM, da Cunha Sauma MF, dos Santos EJ, Chies JA.

Tissue Antigens. 2014 Apr;83(4):260-6. doi: 10.1111/tan.12311. Epub 2014 Feb 28.

Assessment of nailfold capillaroscopy in systemic sclerosis by different optical magnification methods.

Mazzotti NG, Bredemeier M, Brenol CV, Xavier RM, Cestari TF.

Clin Exp Dermatol. 2014 Mar;39(2):135-41. doi: 10.1111/ced.12254. Epub 2013 Dec 16.

Guidelines for the drug treatment of rheumatoid arthritis.

Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Bernardo WM, Pinheiro Gda R; Sociedade Brasileira de Reumatologia.

Rev Bras Reumatol. 2013 Apr;53(2):158-83. English, Portuguese. No abstract available. Erratum in: Rev Bras Reumatol. 2013 May-Jun;53(3):319. Giorgio, Rina Dalva Neubarth [corrected to Giorgi, Rina Dalva Neubarth].

.

Guidelines for the diagnosis of rheumatoid arthritis.

Mota LM, Cruz BA, Brenola CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Kairalla RA, Kawassaki Ade M, Bernardo WM, Pinheiro Gda R; Sociedade Brasileira de Reumatologia; Sociedade Brasileira de Pneumologia e Tisiologia; Colégio Brasileiro de Radiologia.

Rev Bras Reumatol. 2013 Apr;53(2):141-57. English, Portuguese. No abstract available. Erratum in: Rev Bras Reumatol. 2013 May-Jun;53(3):319. Brenol, Claiton Viegas [corrected to Brenola, Claiton Viegas]; Giorgio, Rina Dalva Neubarth [corrected to Giorgi, Rina Dalva Neubarth].

Assessing rheumatoid arthritis disease activity with ultrasound.

Chakr RM, Mendonça JA, Brenol CV, Xavier RM, Brenol JC.

Clin Rheumatol. 2013 Sep;32(9):1249-54. doi: 10.1007/s10067-013-2291-6. Epub 2013 May 23. Review.

2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis.

Brenol CV, da Mota LM, Cruz BA, Pileggi GS, Pereira IA, Rezende LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Pinheiro Gda R; Brazilian Society of Rheumatology.

Rev Bras Reumatol. 2013 Feb;53(1):4-23. English, Portuguese.

Vaccination for patients with rheumatoid arthritis: a pressing need.

Brenol CV, Pileggi GS.

Rev Bras Reumatol. 2013 Feb;53(1):1-3. English, Portuguese. No abstract available.

2012 Brazilian Society of Rheumatology Consensus on the management of comorbidities in patients with rheumatoid arthritis.

Pereira IA, Mota LM, Cruz BA, Brenol CV, Fronza LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Pinheiro Gda R; Brazilian Society of Rheumatology.

Rev Bras Reumatol. 2012 Aug;52(4):474-95. English, Portuguese. Erratum in: Rev Bras Reumatol. 2012 Oct;52(5):815.

2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis.

da Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, de Freitas MV, da Silva NA, Louzada-Júnior P, Giorgi RD, Lima RA, da Rocha Castelar Pinheiro G; Brazilian Society of Rheumatology.

Rev Bras Reumatol. 2012 Mar-Apr;52(2):152-74. English, Portuguese.

Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.

da Cunha VR, Brenol CV, Brenol JC, Fuchs SC, Arlindo EM, Melo IM, Machado CA, de Castro Chaves H Jr, Xavier RM.

Scand J Rheumatol. 2012 May;41(3):186-91. doi: 10.3109/03009742.2011.626443. Epub 2012 Mar 15.

The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases.

Brenol CV, Veit TD, Chies JA, Xavier RM.

Rev Bras Reumatol. 2012 Jan-Feb;52(1):82-91. Review. English, Portuguese.

Mannose-binding lectin gene polymorphisms in Brazilian patients with rheumatoid arthritis.

Martiny FL, Veit TD, Brenol CV, Brenol JC, Xavier RM, Bogo MR, Chies JA.

J Rheumatol. 2012 Jan;39(1):6-9. doi: 10.3899/jrheum.110052. Epub 2011 Oct 15.

Rheumatoid arthritis and metabolic syndrome.

da Cunha VR, Brenol CV, Brenol JC, Xavier RM.

Rev Bras Reumatol. 2011 May-Jun;51(3):260-8. Review. English, Portuguese. Erratum in: Rev Bras Reumatol. 2011 Aug;51(4). doi:10.1590/S0482-50042011000400013.

2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis.

da Mota LM, Cruz BA, Brenol CV, Pereira IA, Fronza LS, Bertolo MB, de Freitas MV, da Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Pinheiro Gda R; Brazilian Society of Rheumatology.

Rev Bras Reumatol. 2011 May-Jun;51(3):199-219. English, Portuguese.

.

Role of endothelial nitric oxide synthase (eNOS) polymorphisms in cardiovascular disease and rheumatoid arthritis.

Brenol CV, Chies JA, Brenol JC, Xavier RM.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):584; author reply 584-5. Epub 2010 Sep 1. No abstract available.

Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.

Scherer S, de Souza TB, de Paoli J, Brenol CV, Xavier RM, Brenol JC, Chies JA, Simon D.

Rheumatol Int. 2010 Jan;30(3):369-73. doi: 10.1007/s00296-009-0974-8. Epub 2009 Jun 6.

Association between the aggrecan gene and rheumatoid arthritis.

de Souza TB, Mentz EF, Brenol CV, Xavier RM, Brenol JC, Chies JA, Simon D.

J Rheumatol. 2008 Dec;35(12):2325-8. doi: 10.3899/jrheum.071326. Epub 2008 Nov 1.

Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis.

Souza LS, Machado SH, Brenol CV, Brenol JC, Xavier RM.

J Rheumatol. 2008 Nov;35(11):2265-71. Epub 2008 Oct 1.

Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations.

Brenol CV, Chies JA, Brenol JC, Monticielo OA, Franciscatto P, Birriel F, Neves AG, Xavier RM.

Clin Rheumatol. 2009 Feb;28(2):201-5. doi: 10.1007/s10067-008-1018-6. Epub 2008 Oct 2.

Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats.

Oliveira PG, Brenol CV, Edelweiss MI, Brenol JC, Petronilho F, Roesler R, Dal-Pizzol F, Schwartsmann G, Xavier RM.

Peptides. 2008 Oct;29(10):1726-31. doi: 10.1016/j.peptides.2008.05.031. Epub 2008 Jun 12.

Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis.

Veit TD, Vianna P, Scheibel I, Brenol CV, Brenol JC, Xavier RM, Delgado-Cañedo A, Gutierrez JE, Brandalize AP, Schuler-Faccini L, Chies JA.

Tissue Antigens. 2008 May;71(5):440-6. doi: 10.1111/j.1399-0039.2008.01019.x. Epub 2008 Mar 10. Erratum in: Tissue Antigens. 2008 Aug;72(2):185. Brenol, Claiton [corrected to Brenol, Claiton Viegas].

Subcutaneous inflammation (panniculitis) in tibio-tarsal joint of rats inoculated with complete Freund's adjuvant.

Oliveira PG, Brenol CV, Edelweiss MI, Meurer L, Brenol JC, Xavier RM.

Clin Exp Med. 2007 Dec;7(4):184-7. doi: 10.1007/s10238-007-0148-6. Epub 2008 Jan 11.

The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.

Kohem CL, Brenol JC, Xavier RM, Bredemeier M, Brenol CV, Dedavid e Silva TL, de Castilhos Mello A, Cañedo AD, Neves AG, Chies JA.

Scand J Rheumatol. 2007 Sep-Oct;36(5):359-64.

[Rheumatoid arthritis and atherosclerosis].

Brenol CV, Monticielo OA, Xavier RM, Brenol JC.

Rev Assoc Med Bras (1992). 2007 Sep-Oct;53(5):465-70. Review. Portuguese.

Wzap 2.png